| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 江苏浩欧博生物医药股份有限公司（HOB）是由用国家级重大引进人才、海外留学归国人员创立的高科技企业，专注于体外诊断领域中的过敏和自身免疫疾病诊断试剂的研发和生产，致力于为广大患者提供“用得起、用得放心”的检测产品。 公司自2009年成立以来，一直专注于过敏和自身免疫疾病诊断领域。经过持续投入和高速发展，HOB已经发展成为一个集创新研发、规模生产、质量控制和市场营销为一体的现代化高科技企业。依靠自主研发的核心技术，有效填补了国内市场需求。公司提供丰富的产品系列，满足市场多样化的检测需求，逐步成为我国过敏原检测领域的领先者和自身免疫疾病诊断领域的后起之秀。 创业十年以来，公司已获得一百余项国家药品监督管理局认证的产品注册证、数十项专利、并获得“苏州市过敏原诊断工程技术研究中心”、“江苏省免疫诊断工程技术研究中心”、苏州市“创新先锋企业”、“瞪羚企业”等荣誉称号。HOB坚持以客户为中心，不断提升服务能力，打造了一支遍布全国34个省/直辖市的营销服务团队，为客户提供专业、及时、完善的技术服务。 HOB本着“立足国内，面向全球”的战略发展策略，在为国内客户提供良好的体外诊断产品解决方案的同时，还积极开拓国际市场，通过进入质量标准更高且竞争更加激烈的国际市场（包括北美和欧洲），为企业发展寻找更广阔的空间。 | ||||||||||||||||||||||||
| Main Business | 专业从事体外诊断试剂的研发、生产和销售。 | ||||||||||||||||||||||||
| Legal Representative | JOHN LI | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 谢爱香 | ||||||||||||||||||||||||
| Solicitors | 国浩律师（上海）事务所 | ||||||||||||||||||||||||
| Auditors | 立信会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0512-69561996 | ||||||||||||||||||||||||
| Fax No | 0512-62956652 | ||||||||||||||||||||||||
| Website | www.hob-biotech.com | ||||||||||||||||||||||||
| jshob@hob-biotech.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 13/01/2021 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.750 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.400 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 12.857 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 7.242B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |